Request for Covid-19 Impact Assessment of this Report
The United States Meloxicam market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Meloxicam market, reaching US$ million by the year 2028. As for the Europe Meloxicam landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Meloxicam players cover Boehringer Ingelheim, Baudax, Perrigo, and Recro Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Meloxicam market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
by Ingredient
Combination Drugs
Prescribed Drugs
by Route
Oral
Intravenou
by Dosage Form
Tablets
Capsule
Granules
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Rheumatoid Arthritis
Osteoarthritis
Soft Tissue Inflammation
Traumatic Pain
Post-Operative Pain
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Boehringer Ingelheim
Baudax
Perrigo
Recro Pharma
Iroko Pharma
Zyla Life Sciences
Axsome Therapeutics
Orbis Biosciences
Cellix Bio
Ligand Pharma
SEDOR Pharma
Heron Therapeutics
Pacira BioSciences
Sanofi
Eurofarma Laboratorio
TerSera Therapeutics
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma
Shanghai Bolinger Ingelheim Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Sichuan Shenghe Pharmaceutical
Ningxia Kangya Pharmaceutical
Yangtze Pharmaceutical Group
Kunshan Longdeng Ruidi Pharmaceutical
Jiangsu Yabang Epson Pharmaceutical
Jiangsu Feima Pharmaceutical Co. , Ltd
Zhejiang Xianju Pharmaceutical
Hainan All Star Pharmaceutical
Hainan Aomeihua Pharmaceutical
Hunan Mingrui Pharmaceutical
Suzhou Sinochem Pharmaceutical
Qilu Pharmaceutical
Sichuan Luye Pharmaceutical
Shandong Xinhua Pharmaceutical
Guangdong Renkang Pharmaceutical
Hainan Selike Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meloxicam Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Meloxicam by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Meloxicam by Country/Region, 2017, 2022 & 2028
2.2 Meloxicam Segment by Type
2.2.1 Combination Drugs
2.2.2 Prescribed Drugs
2.3 Meloxicam Sales by Type
2.3.1 Global Meloxicam Sales Market Share by Type (2017-2022)
2.3.2 Global Meloxicam Revenue and Market Share by Type (2017-2022)
2.3.3 Global Meloxicam Sale Price by Type (2017-2022)
2.4 Meloxicam Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Osteoarthritis
2.4.3 Soft Tissue Inflammation
2.4.4 Traumatic Pain
2.4.5 Post-Operative Pain
2.4.6 Other
2.5 Meloxicam Sales by Application
2.5.1 Global Meloxicam Sale Market Share by Application (2017-2022)
2.5.2 Global Meloxicam Revenue and Market Share by Application (2017-2022)
2.5.3 Global Meloxicam Sale Price by Application (2017-2022)
3 Global Meloxicam by Company
3.1 Global Meloxicam Breakdown Data by Company
3.1.1 Global Meloxicam Annual Sales by Company (2020-2022)
3.1.2 Global Meloxicam Sales Market Share by Company (2020-2022)
3.2 Global Meloxicam Annual Revenue by Company (2020-2022)
3.2.1 Global Meloxicam Revenue by Company (2020-2022)
3.2.2 Global Meloxicam Revenue Market Share by Company (2020-2022)
3.3 Global Meloxicam Sale Price by Company
3.4 Key Manufacturers Meloxicam Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meloxicam Product Location Distribution
3.4.2 Players Meloxicam Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Meloxicam by Geographic Region
4.1 World Historic Meloxicam Market Size by Geographic Region (2017-2022)
4.1.1 Global Meloxicam Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Meloxicam Annual Revenue by Geographic Region
4.2 World Historic Meloxicam Market Size by Country/Region (2017-2022)
4.2.1 Global Meloxicam Annual Sales by Country/Region (2017-2022)
4.2.2 Global Meloxicam Annual Revenue by Country/Region
4.3 Americas Meloxicam Sales Growth
4.4 APAC Meloxicam Sales Growth
4.5 Europe Meloxicam Sales Growth
4.6 Middle East & Africa Meloxicam Sales Growth
5 Americas
5.1 Americas Meloxicam Sales by Country
5.1.1 Americas Meloxicam Sales by Country (2017-2022)
5.1.2 Americas Meloxicam Revenue by Country (2017-2022)
5.2 Americas Meloxicam Sales by Type
5.3 Americas Meloxicam Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meloxicam Sales by Region
6.1.1 APAC Meloxicam Sales by Region (2017-2022)
6.1.2 APAC Meloxicam Revenue by Region (2017-2022)
6.2 APAC Meloxicam Sales by Type
6.3 APAC Meloxicam Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Meloxicam by Country
7.1.1 Europe Meloxicam Sales by Country (2017-2022)
7.1.2 Europe Meloxicam Revenue by Country (2017-2022)
7.2 Europe Meloxicam Sales by Type
7.3 Europe Meloxicam Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Meloxicam by Country
8.1.1 Middle East & Africa Meloxicam Sales by Country (2017-2022)
8.1.2 Middle East & Africa Meloxicam Revenue by Country (2017-2022)
8.2 Middle East & Africa Meloxicam Sales by Type
8.3 Middle East & Africa Meloxicam Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meloxicam
10.3 Manufacturing Process Analysis of Meloxicam
10.4 Industry Chain Structure of Meloxicam
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meloxicam Distributors
11.3 Meloxicam Customer
12 World Forecast Review for Meloxicam by Geographic Region
12.1 Global Meloxicam Market Size Forecast by Region
12.1.1 Global Meloxicam Forecast by Region (2023-2028)
12.1.2 Global Meloxicam Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meloxicam Forecast by Type
12.7 Global Meloxicam Forecast by Application
13 Key Players Analysis
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Meloxicam Product Offered
13.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Baudax
13.2.1 Baudax Company Information
13.2.2 Baudax Meloxicam Product Offered
13.2.3 Baudax Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Baudax Main Business Overview
13.2.5 Baudax Latest Developments
13.3 Perrigo
13.3.1 Perrigo Company Information
13.3.2 Perrigo Meloxicam Product Offered
13.3.3 Perrigo Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Perrigo Main Business Overview
13.3.5 Perrigo Latest Developments
13.4 Recro Pharma
13.4.1 Recro Pharma Company Information
13.4.2 Recro Pharma Meloxicam Product Offered
13.4.3 Recro Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Recro Pharma Main Business Overview
13.4.5 Recro Pharma Latest Developments
13.5 Iroko Pharma
13.5.1 Iroko Pharma Company Information
13.5.2 Iroko Pharma Meloxicam Product Offered
13.5.3 Iroko Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Iroko Pharma Main Business Overview
13.5.5 Iroko Pharma Latest Developments
13.6 Zyla Life Sciences
13.6.1 Zyla Life Sciences Company Information
13.6.2 Zyla Life Sciences Meloxicam Product Offered
13.6.3 Zyla Life Sciences Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Zyla Life Sciences Main Business Overview
13.6.5 Zyla Life Sciences Latest Developments
13.7 Axsome Therapeutics
13.7.1 Axsome Therapeutics Company Information
13.7.2 Axsome Therapeutics Meloxicam Product Offered
13.7.3 Axsome Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Axsome Therapeutics Main Business Overview
13.7.5 Axsome Therapeutics Latest Developments
13.8 Orbis Biosciences
13.8.1 Orbis Biosciences Company Information
13.8.2 Orbis Biosciences Meloxicam Product Offered
13.8.3 Orbis Biosciences Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Orbis Biosciences Main Business Overview
13.8.5 Orbis Biosciences Latest Developments
13.9 Cellix Bio
13.9.1 Cellix Bio Company Information
13.9.2 Cellix Bio Meloxicam Product Offered
13.9.3 Cellix Bio Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Cellix Bio Main Business Overview
13.9.5 Cellix Bio Latest Developments
13.10 Ligand Pharma
13.10.1 Ligand Pharma Company Information
13.10.2 Ligand Pharma Meloxicam Product Offered
13.10.3 Ligand Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Ligand Pharma Main Business Overview
13.10.5 Ligand Pharma Latest Developments
13.11 SEDOR Pharma
13.11.1 SEDOR Pharma Company Information
13.11.2 SEDOR Pharma Meloxicam Product Offered
13.11.3 SEDOR Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 SEDOR Pharma Main Business Overview
13.11.5 SEDOR Pharma Latest Developments
13.12 Heron Therapeutics
13.12.1 Heron Therapeutics Company Information
13.12.2 Heron Therapeutics Meloxicam Product Offered
13.12.3 Heron Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Heron Therapeutics Main Business Overview
13.12.5 Heron Therapeutics Latest Developments
13.13 Pacira BioSciences
13.13.1 Pacira BioSciences Company Information
13.13.2 Pacira BioSciences Meloxicam Product Offered
13.13.3 Pacira BioSciences Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Pacira BioSciences Main Business Overview
13.13.5 Pacira BioSciences Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Meloxicam Product Offered
13.14.3 Sanofi Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Eurofarma Laboratorio
13.15.1 Eurofarma Laboratorio Company Information
13.15.2 Eurofarma Laboratorio Meloxicam Product Offered
13.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Eurofarma Laboratorio Main Business Overview
13.15.5 Eurofarma Laboratorio Latest Developments
13.16 TerSera Therapeutics
13.16.1 TerSera Therapeutics Company Information
13.16.2 TerSera Therapeutics Meloxicam Product Offered
13.16.3 TerSera Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 TerSera Therapeutics Main Business Overview
13.16.5 TerSera Therapeutics Latest Developments
13.17 Apotex
13.17.1 Apotex Company Information
13.17.2 Apotex Meloxicam Product Offered
13.17.3 Apotex Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Apotex Main Business Overview
13.17.5 Apotex Latest Developments
13.18 Yung Shin Pharmaceutical
13.18.1 Yung Shin Pharmaceutical Company Information
13.18.2 Yung Shin Pharmaceutical Meloxicam Product Offered
13.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Yung Shin Pharmaceutical Main Business Overview
13.18.5 Yung Shin Pharmaceutical Latest Developments
13.19 Breckenridge Pharmaceutical
13.19.1 Breckenridge Pharmaceutical Company Information
13.19.2 Breckenridge Pharmaceutical Meloxicam Product Offered
13.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Breckenridge Pharmaceutical Main Business Overview
13.19.5 Breckenridge Pharmaceutical Latest Developments
13.20 Zydus Pharmaceuticals
13.20.1 Zydus Pharmaceuticals Company Information
13.20.2 Zydus Pharmaceuticals Meloxicam Product Offered
13.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Zydus Pharmaceuticals Main Business Overview
13.20.5 Zydus Pharmaceuticals Latest Developments
13.21 Unichem Pharmaceuticals
13.21.1 Unichem Pharmaceuticals Company Information
13.21.2 Unichem Pharmaceuticals Meloxicam Product Offered
13.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Unichem Pharmaceuticals Main Business Overview
13.21.5 Unichem Pharmaceuticals Latest Developments
13.22 Strides Pharma
13.22.1 Strides Pharma Company Information
13.22.2 Strides Pharma Meloxicam Product Offered
13.22.3 Strides Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Strides Pharma Main Business Overview
13.22.5 Strides Pharma Latest Developments
13.23 Cipla
13.23.1 Cipla Company Information
13.23.2 Cipla Meloxicam Product Offered
13.23.3 Cipla Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Cipla Main Business Overview
13.23.5 Cipla Latest Developments
13.24 Dr. Reddy's Laboratories
13.24.1 Dr. Reddy's Laboratories Company Information
13.24.2 Dr. Reddy's Laboratories Meloxicam Product Offered
13.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Dr. Reddy's Laboratories Main Business Overview
13.24.5 Dr. Reddy's Laboratories Latest Developments
13.25 Glenmark Pharmaceuticals
13.25.1 Glenmark Pharmaceuticals Company Information
13.25.2 Glenmark Pharmaceuticals Meloxicam Product Offered
13.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 Glenmark Pharmaceuticals Main Business Overview
13.25.5 Glenmark Pharmaceuticals Latest Developments
13.26 Teva
13.26.1 Teva Company Information
13.26.2 Teva Meloxicam Product Offered
13.26.3 Teva Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 Teva Main Business Overview
13.26.5 Teva Latest Developments
13.27 PuraCap Pharmaceutical
13.27.1 PuraCap Pharmaceutical Company Information
13.27.2 PuraCap Pharmaceutical Meloxicam Product Offered
13.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 PuraCap Pharmaceutical Main Business Overview
13.27.5 PuraCap Pharmaceutical Latest Developments
13.28 TARO
13.28.1 TARO Company Information
13.28.2 TARO Meloxicam Product Offered
13.28.3 TARO Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.28.4 TARO Main Business Overview
13.28.5 TARO Latest Developments
13.29 Lupin Pharmaceuticals
13.29.1 Lupin Pharmaceuticals Company Information
13.29.2 Lupin Pharmaceuticals Meloxicam Product Offered
13.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.29.4 Lupin Pharmaceuticals Main Business Overview
13.29.5 Lupin Pharmaceuticals Latest Developments
13.30 Aurobindo Pharma
13.30.1 Aurobindo Pharma Company Information
13.30.2 Aurobindo Pharma Meloxicam Product Offered
13.30.3 Aurobindo Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)
13.30.4 Aurobindo Pharma Main Business Overview
13.30.5 Aurobindo Pharma Latest Developments
13.31 Shanghai Bolinger Ingelheim Pharmaceutical
13.32 Shanghai Zhaohui Pharmaceutical
13.33 Sichuan Shenghe Pharmaceutical
13.34 Ningxia Kangya Pharmaceutical
13.35 Yangtze Pharmaceutical Group
13.36 Kunshan Longdeng Ruidi Pharmaceutical
13.37 Jiangsu Yabang Epson Pharmaceutical
13.38 Jiangsu Feima Pharmaceutical Co. , Ltd
13.39 Zhejiang Xianju Pharmaceutical
13.40 Hainan All Star Pharmaceutical
13.41 Hainan Aomeihua Pharmaceutical
13.42 Hunan Mingrui Pharmaceutical
13.43 Suzhou Sinochem Pharmaceutical
13.44 Qilu Pharmaceutical
13.45 Sichuan Luye Pharmaceutical
13.46 Shandong Xinhua Pharmaceutical
13.47 Guangdong Renkang Pharmaceutical
13.48 Hainan Selike Pharmaceutical
14 Research Findings and Conclusion
Table 1. Meloxicam Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Meloxicam Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Combination Drugs
Table 4. Major Players of Prescribed Drugs
Table 5. Global Meloxicam Sales by Type (2017-2022) & (KG)
Table 6. Global Meloxicam Sales Market Share by Type (2017-2022)
Table 7. Global Meloxicam Revenue by Type (2017-2022) & ($ million)
Table 8. Global Meloxicam Revenue Market Share by Type (2017-2022)
Table 9. Global Meloxicam Sale Price by Type (2017-2022) & (US$/G)
Table 10. Global Meloxicam Sales by Application (2017-2022) & (KG)
Table 11. Global Meloxicam Sales Market Share by Application (2017-2022)
Table 12. Global Meloxicam Revenue by Application (2017-2022)
Table 13. Global Meloxicam Revenue Market Share by Application (2017-2022)
Table 14. Global Meloxicam Sale Price by Application (2017-2022) & (US$/G)
Table 15. Global Meloxicam Sales by Company (2020-2022) & (KG)
Table 16. Global Meloxicam Sales Market Share by Company (2020-2022)
Table 17. Global Meloxicam Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Meloxicam Revenue Market Share by Company (2020-2022)
Table 19. Global Meloxicam Sale Price by Company (2020-2022) & (US$/G)
Table 20. Key Manufacturers Meloxicam Producing Area Distribution and Sales Area
Table 21. Players Meloxicam Products Offered
Table 22. Meloxicam Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Meloxicam Sales by Geographic Region (2017-2022) & (KG)
Table 26. Global Meloxicam Sales Market Share Geographic Region (2017-2022)
Table 27. Global Meloxicam Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Meloxicam Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Meloxicam Sales by Country/Region (2017-2022) & (KG)
Table 30. Global Meloxicam Sales Market Share by Country/Region (2017-2022)
Table 31. Global Meloxicam Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Meloxicam Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Meloxicam Sales by Country (2017-2022) & (KG)
Table 34. Americas Meloxicam Sales Market Share by Country (2017-2022)
Table 35. Americas Meloxicam Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Meloxicam Revenue Market Share by Country (2017-2022)
Table 37. Americas Meloxicam Sales by Type (2017-2022) & (KG)
Table 38. Americas Meloxicam Sales Market Share by Type (2017-2022)
Table 39. Americas Meloxicam Sales by Application (2017-2022) & (KG)
Table 40. Americas Meloxicam Sales Market Share by Application (2017-2022)
Table 41. APAC Meloxicam Sales by Region (2017-2022) & (KG)
Table 42. APAC Meloxicam Sales Market Share by Region (2017-2022)
Table 43. APAC Meloxicam Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Meloxicam Revenue Market Share by Region (2017-2022)
Table 45. APAC Meloxicam Sales by Type (2017-2022) & (KG)
Table 46. APAC Meloxicam Sales Market Share by Type (2017-2022)
Table 47. APAC Meloxicam Sales by Application (2017-2022) & (KG)
Table 48. APAC Meloxicam Sales Market Share by Application (2017-2022)
Table 49. Europe Meloxicam Sales by Country (2017-2022) & (KG)
Table 50. Europe Meloxicam Sales Market Share by Country (2017-2022)
Table 51. Europe Meloxicam Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Meloxicam Revenue Market Share by Country (2017-2022)
Table 53. Europe Meloxicam Sales by Type (2017-2022) & (KG)
Table 54. Europe Meloxicam Sales Market Share by Type (2017-2022)
Table 55. Europe Meloxicam Sales by Application (2017-2022) & (KG)
Table 56. Europe Meloxicam Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Meloxicam Sales by Country (2017-2022) & (KG)
Table 58. Middle East & Africa Meloxicam Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Meloxicam Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Meloxicam Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Meloxicam Sales by Type (2017-2022) & (KG)
Table 62. Middle East & Africa Meloxicam Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Meloxicam Sales by Application (2017-2022) & (KG)
Table 64. Middle East & Africa Meloxicam Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Meloxicam
Table 66. Key Market Challenges & Risks of Meloxicam
Table 67. Key Industry Trends of Meloxicam
Table 68. Meloxicam Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Meloxicam Distributors List
Table 71. Meloxicam Customer List
Table 72. Global Meloxicam Sales Forecast by Region (2023-2028) & (KG)
Table 73. Global Meloxicam Sales Market Forecast by Region
Table 74. Global Meloxicam Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Meloxicam Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Meloxicam Sales Forecast by Country (2023-2028) & (KG)
Table 77. Americas Meloxicam Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Meloxicam Sales Forecast by Region (2023-2028) & (KG)
Table 79. APAC Meloxicam Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Meloxicam Sales Forecast by Country (2023-2028) & (KG)
Table 81. Europe Meloxicam Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Meloxicam Sales Forecast by Country (2023-2028) & (KG)
Table 83. Middle East & Africa Meloxicam Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Meloxicam Sales Forecast by Type (2023-2028) & (KG)
Table 85. Global Meloxicam Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Meloxicam Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Meloxicam Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Meloxicam Sales Forecast by Application (2023-2028) & (KG)
Table 89. Global Meloxicam Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Meloxicam Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Meloxicam Revenue Market Share Forecast by Application (2023-2028)
Table 92. Boehringer Ingelheim Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 93. Boehringer Ingelheim Meloxicam Product Offered
Table 94. Boehringer Ingelheim Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 95. Boehringer Ingelheim Main Business
Table 96. Boehringer Ingelheim Latest Developments
Table 97. Baudax Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 98. Baudax Meloxicam Product Offered
Table 99. Baudax Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 100. Baudax Main Business
Table 101. Baudax Latest Developments
Table 102. Perrigo Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 103. Perrigo Meloxicam Product Offered
Table 104. Perrigo Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 105. Perrigo Main Business
Table 106. Perrigo Latest Developments
Table 107. Recro Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 108. Recro Pharma Meloxicam Product Offered
Table 109. Recro Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 110. Recro Pharma Main Business
Table 111. Recro Pharma Latest Developments
Table 112. Iroko Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 113. Iroko Pharma Meloxicam Product Offered
Table 114. Iroko Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 115. Iroko Pharma Main Business
Table 116. Iroko Pharma Latest Developments
Table 117. Zyla Life Sciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 118. Zyla Life Sciences Meloxicam Product Offered
Table 119. Zyla Life Sciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 120. Zyla Life Sciences Main Business
Table 121. Zyla Life Sciences Latest Developments
Table 122. Axsome Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 123. Axsome Therapeutics Meloxicam Product Offered
Table 124. Axsome Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 125. Axsome Therapeutics Main Business
Table 126. Axsome Therapeutics Latest Developments
Table 127. Orbis Biosciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 128. Orbis Biosciences Meloxicam Product Offered
Table 129. Orbis Biosciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 130. Orbis Biosciences Main Business
Table 131. Orbis Biosciences Latest Developments
Table 132. Cellix Bio Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 133. Cellix Bio Meloxicam Product Offered
Table 134. Cellix Bio Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 135. Cellix Bio Main Business
Table 136. Cellix Bio Latest Developments
Table 137. Ligand Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 138. Ligand Pharma Meloxicam Product Offered
Table 139. Ligand Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 140. Ligand Pharma Main Business
Table 141. Ligand Pharma Latest Developments
Table 142. SEDOR Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 143. SEDOR Pharma Meloxicam Product Offered
Table 144. SEDOR Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 145. SEDOR Pharma Main Business
Table 146. SEDOR Pharma Latest Developments
Table 147. Heron Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 148. Heron Therapeutics Meloxicam Product Offered
Table 149. Heron Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 150. Heron Therapeutics Main Business
Table 151. Heron Therapeutics Latest Developments
Table 152. Pacira BioSciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 153. Pacira BioSciences Meloxicam Product Offered
Table 154. Pacira BioSciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 155. Pacira BioSciences Main Business
Table 156. Pacira BioSciences Latest Developments
Table 157. Sanofi Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 158. Sanofi Meloxicam Product Offered
Table 159. Sanofi Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 160. Sanofi Main Business
Table 161. Sanofi Latest Developments
Table 162. Eurofarma Laboratorio Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 163. Eurofarma Laboratorio Meloxicam Product Offered
Table 164. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 165. Eurofarma Laboratorio Main Business
Table 166. Eurofarma Laboratorio Latest Developments
Table 167. TerSera Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 168. TerSera Therapeutics Meloxicam Product Offered
Table 169. TerSera Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 170. TerSera Therapeutics Main Business
Table 171. TerSera Therapeutics Latest Developments
Table 172. Apotex Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 173. Apotex Meloxicam Product Offered
Table 174. Apotex Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 175. Apotex Main Business
Table 176. Apotex Latest Developments
Table 177. Yung Shin Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 178. Yung Shin Pharmaceutical Meloxicam Product Offered
Table 179. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 180. Yung Shin Pharmaceutical Main Business
Table 181. Yung Shin Pharmaceutical Latest Developments
Table 182. Breckenridge Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 183. Breckenridge Pharmaceutical Meloxicam Product Offered
Table 184. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 185. Breckenridge Pharmaceutical Main Business
Table 186. Breckenridge Pharmaceutical Latest Developments
Table 187. Zydus Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 188. Zydus Pharmaceuticals Meloxicam Product Offered
Table 189. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 190. Zydus Pharmaceuticals Main Business
Table 191. Zydus Pharmaceuticals Latest Developments
Table 192. Unichem Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 193. Unichem Pharmaceuticals Meloxicam Product Offered
Table 194. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 195. Unichem Pharmaceuticals Main Business
Table 196. Unichem Pharmaceuticals Latest Developments
Table 197. Strides Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 198. Strides Pharma Meloxicam Product Offered
Table 199. Strides Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 200. Strides Pharma Main Business
Table 201. Strides Pharma Latest Developments
Table 202. Cipla Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 203. Cipla Meloxicam Product Offered
Table 204. Cipla Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 205. Cipla Main Business
Table 206. Cipla Latest Developments
Table 207. Dr. Reddy's Laboratories Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 208. Dr. Reddy's Laboratories Meloxicam Product Offered
Table 209. Dr. Reddy's Laboratories Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 210. Dr. Reddy's Laboratories Main Business
Table 211. Dr. Reddy's Laboratories Latest Developments
Table 212. Glenmark Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 213. Glenmark Pharmaceuticals Meloxicam Product Offered
Table 214. Glenmark Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 215. Glenmark Pharmaceuticals Main Business
Table 216. Glenmark Pharmaceuticals Latest Developments
Table 217. Teva Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 218. Teva Meloxicam Product Offered
Table 219. Teva Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 220. Teva Main Business
Table 221. Teva Latest Developments
Table 222. PuraCap Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 223. PuraCap Pharmaceutical Meloxicam Product Offered
Table 224. PuraCap Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 225. PuraCap Pharmaceutical Main Business
Table 226. PuraCap Pharmaceutical Latest Developments
Table 227. TARO Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 228. TARO Meloxicam Product Offered
Table 229. TARO Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 230. TARO Main Business
Table 231. TARO Latest Developments
Table 232. Lupin Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 233. Lupin Pharmaceuticals Meloxicam Product Offered
Table 234. Lupin Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 235. Lupin Pharmaceuticals Main Business
Table 236. Lupin Pharmaceuticals Latest Developments
Table 237. Aurobindo Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 238. Aurobindo Pharma Meloxicam Product Offered
Table 239. Aurobindo Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 240. Aurobindo Pharma Main Business
Table 241. Aurobindo Pharma Latest Developments
Table 242. Shanghai Bolinger Ingelheim Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 243. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Product Offered
Table 244. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 245. Shanghai Bolinger Ingelheim Pharmaceutical Main Business
Table 246. Shanghai Bolinger Ingelheim Pharmaceutical Latest Developments
Table 247. Shanghai Zhaohui Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 248. Shanghai Zhaohui Pharmaceutical Meloxicam Product Offered
Table 249. Shanghai Zhaohui Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 250. Shanghai Zhaohui Pharmaceutical Main Business
Table 251. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 252. Sichuan Shenghe Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 253. Sichuan Shenghe Pharmaceutical Meloxicam Product Offered
Table 254. Sichuan Shenghe Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 255. Sichuan Shenghe Pharmaceutical Main Business
Table 256. Sichuan Shenghe Pharmaceutical Latest Developments
Table 257. Ningxia Kangya Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 258. Ningxia Kangya Pharmaceutical Meloxicam Product Offered
Table 259. Ningxia Kangya Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 260. Ningxia Kangya Pharmaceutical Main Business
Table 261. Ningxia Kangya Pharmaceutical Latest Developments
Table 262. Yangtze Pharmaceutical Group Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 263. Yangtze Pharmaceutical Group Meloxicam Product Offered
Table 264. Yangtze Pharmaceutical Group Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 265. Yangtze Pharmaceutical Group Main Business
Table 266. Yangtze Pharmaceutical Group Latest Developments
Table 267. Kunshan Longdeng Ruidi Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 268. Jiangsu Yabang Epson Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 269. Jiangsu Feima Pharmaceutical Co. , Ltd Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 270. Zhejiang Xianju Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 271. Hainan All Star Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 272. Hainan Aomeihua Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 273. Hunan Mingrui Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 274. Suzhou Sinochem Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 275. Qilu Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 276. Sichuan Luye Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 277. Shandong Xinhua Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 278. Guangdong Renkang Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 279. Hainan Selike Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Meloxicam
Figure 2. Meloxicam Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meloxicam Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Meloxicam Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Meloxicam Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Combination Drugs
Figure 10. Product Picture of Prescribed Drugs
Figure 11. Global Meloxicam Sales Market Share by Type in 2021
Figure 12. Global Meloxicam Revenue Market Share by Type (2017-2022)
Figure 13. Meloxicam Consumed in Rheumatoid Arthritis
Figure 14. Global Meloxicam Market: Rheumatoid Arthritis (2017-2022) & (KG)
Figure 15. Meloxicam Consumed in Osteoarthritis
Figure 16. Global Meloxicam Market: Osteoarthritis (2017-2022) & (KG)
Figure 17. Meloxicam Consumed in Soft Tissue Inflammation
Figure 18. Global Meloxicam Market: Soft Tissue Inflammation (2017-2022) & (KG)
Figure 19. Meloxicam Consumed in Traumatic Pain
Figure 20. Global Meloxicam Market: Traumatic Pain (2017-2022) & (KG)
Figure 21. Meloxicam Consumed in Post-Operative Pain
Figure 22. Global Meloxicam Market: Post-Operative Pain (2017-2022) & (KG)
Figure 23. Meloxicam Consumed in Other
Figure 24. Global Meloxicam Market: Other (2017-2022) & (KG)
Figure 25. Global Meloxicam Sales Market Share by Application (2017-2022)
Figure 26. Global Meloxicam Revenue Market Share by Application in 2021
Figure 27. Meloxicam Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Meloxicam Revenue Market Share by Company in 2021
Figure 29. Global Meloxicam Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Meloxicam Revenue Market Share by Geographic Region in 2021
Figure 31. Global Meloxicam Sales Market Share by Region (2017-2022)
Figure 32. Global Meloxicam Revenue Market Share by Country/Region in 2021
Figure 33. Americas Meloxicam Sales 2017-2022 (KG)
Figure 34. Americas Meloxicam Revenue 2017-2022 ($ Millions)
Figure 35. APAC Meloxicam Sales 2017-2022 (KG)
Figure 36. APAC Meloxicam Revenue 2017-2022 ($ Millions)
Figure 37. Europe Meloxicam Sales 2017-2022 (KG)
Figure 38. Europe Meloxicam Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Meloxicam Sales 2017-2022 (KG)
Figure 40. Middle East & Africa Meloxicam Revenue 2017-2022 ($ Millions)
Figure 41. Americas Meloxicam Sales Market Share by Country in 2021
Figure 42. Americas Meloxicam Revenue Market Share by Country in 2021
Figure 43. United States Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Meloxicam Sales Market Share by Region in 2021
Figure 48. APAC Meloxicam Revenue Market Share by Regions in 2021
Figure 49. China Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Meloxicam Sales Market Share by Country in 2021
Figure 56. Europe Meloxicam Revenue Market Share by Country in 2021
Figure 57. Germany Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Meloxicam Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Meloxicam Revenue Market Share by Country in 2021
Figure 64. Egypt Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Meloxicam Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Meloxicam in 2021
Figure 70. Manufacturing Process Analysis of Meloxicam
Figure 71. Industry Chain Structure of Meloxicam
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...